Reviva Pharmaceuticals I...
1.80
0.22 (13.92%)
At close: Jan 15, 2025, 3:50 PM

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18
PE Ratio -0.00 -3.41 -5.02 -7.07 -34.55 n/a
PS Ratio n/a n/a n/a n/a n/a n/a
PB Ratio 21.43 6.73 1.49 3.60 -4.3 n/a
P/FCF Ratio -4.33 -4.37 -4.01 -7.18 -133.94 n/a
P/OCF Ratio -4.33 -4.37 -4.01 -7.18 -133.94 n/a
OCF/S Ratio n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio n/a n/a n/a n/a -0.55 n/a
Quick Ratio 1.38 3.13 13.39 6.57 0.00 n/a
Current Ratio 1.38 3.13 13.39 6.57 0.00 n/a
Asset Turnover n/a n/a n/a n/a n/a n/a
Interest Coverage n/a -132.97 -4.19K -1.68 -0.8 n/a
Return on Equity (ROE) -6.87M -1.98 -0.3 -0.51 0.12 n/a
Return on Assets (ROA) -1.66M -1.29 -0.27 -0.43 -325.7 -0.03
Return on Capital (ROIC) -6.05M -1.89 -0.35 -0.33 0.06 -0.02
Dividend Yield n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a n/a n/a